Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Techne, 908 Devices Partner on Protein Characterization

NEW YORK – Bio-Techne and 908 Devices said on Tuesday that they are jointly developing an extended workflow for protein characterization.

Specifically, the firms plan to pair Minneapolis-based Bio-Techne's Maurice icIEF protein separation instrument with Boston-based 908 Devices' ZipChip platform, enabling in-depth characterization of intact and near-native biotherapeutics.

908 Devices' open-access ZipChip platform enables high-resolution separation and mass spec sample introduction. It directly integrates electrospray ionization with mass spectrometry and is compatible with Thermo Fisher Scientific, Sciex, and Bruker mass spectrometers. ZipChip uses capillary electrophoresis and electrospray ionization technology to minimize sample prep burden, perform high-resolution separations, and directly introduce samples into a mass spec instrument, according to the firms.

"By partnering with Bio-Techne and leveraging their market leading Maurice icIEF platform with our ZipChip device, we are together extending the workflow for customers conducting detailed protein characterization of charge variants," said Kevin Knopp, CEO and cofounder of 908 Devices, in statement. "This collaboration helps advance our reach into the biopharmaceutical market."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.